- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Tonya Winders Details What She's Excited to See at ERS 2021
Tonya Winders, MBA, CEO and president of the Allergy & Asthma Network, highlights what she is looking forward to at the European Respiratory Society (ERS) International Congress 2021.
Tonya Winders, MBA, CEO and president of the Allergy & Asthma Network, highlights what she is looking forward to at the European Respiratory Society (ERS) International Congress 2021.
Transcript:
What is your session on asthma guidelines going to entail?
So, I'm excited to attend the European Respiratory Society meeting and to participate in this particular session, which highlights the health care system failures for patients that are living with chronic respiratory disease. So, I'll be bringing forth the patient perspective on how current national policies are lacking for so many patients across the world to ensure that they're getting adequate diagnosis, treatment, and management of their chronic respiratory disease.
What other sessions are you looking forward to hearing about?
Well, it's always exciting to be with the world's leaders at the ERS meetings and to hear the latest science when it comes to chronic respiratory disease. So, I'm certainly looking forward to the sessions on asthma and COPD [chronic obstructive pulmonary disease]. I'm very interested in the COVID-19 long haul and how it may be impacting this community specifically. Again, we were seeing that and hearing that directly from the patient community on a daily basis. So, learning what the latest science and thoughts are on COVID-19 long haul and its relationship to asthma and COPD, specifically, is what I'm looking forward to.
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Zanubrutinib Shows Durable Benefit for High-Risk CLL/SLL at 5 Years in SEQUOIA Trial
June 6th 2025Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and deletion of the 17p chromosome, with progression-free survival similar to patients without high-risk disease characteristics.
Read More
Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS
June 5th 2025Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
Read More
At EHA 2025, Hematology Discussions Will Stretch Across Lifespans and Locations
June 5th 2025The 2025 European Hematology Association (EHA) Congress, convening virtually and in Milan, Italy, from June 12 to June 15, 2025, will feature a revamped program structure for the meeting’s 30th anniversary while maintaining ample opportunities to network, debate, and absorb practice-changing findings in hematology and oncology.
Read More
